公司概覽
業務類別 --
業務概覽
公司地址 No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219
電話號碼 +86 2888610620
傳真號碼 --
公司網頁 https://www.keymedbio.com
員工數量 1258
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Changyu Wang Director and Senior Vice President -- 28/04/2025
Dr. Gang Xu Director and Senior Vice President -- 28/04/2025
Dr. Bo Chen, PhD Chairman of the Board and Chief Executive Officer -- 28/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Changyu Wang Director and Senior Vice President 28/04/2025
Mr. Cheuk Kin Stephen Law Independent Director 28/04/2025
Professor Xiao-Fan Wang, PhD Independent Director 28/04/2025
Mr. Qi Chen Director 28/04/2025
Dr. Min Chuan Wang Director 28/04/2025
Mr. Yilun Liu Director 28/04/2025
Professor Yang Ke Independent Director 28/04/2025
Dr. Gang Xu Director and Senior Vice President 28/04/2025
Dr. Bo Chen, PhD Chairman of the Board and Chief Executive Officer 28/04/2025
 
所屬ETF (更新日期: 07/03/2026 03:53)
代號 名稱 佔比% 持有日期
IXUSiShares Core MSCI Total Intl Stk ETF0.16%28/02/2026
VTVanguard Total World Stock ETF0.05%31/01/2026
SPEMState Street® SPDR® Portfolio EM ETF0.05%27/02/2026
FEMSFirst Trust Emerg Mkts SC AlphaDEX® ETF0.04%24/02/2026
ECNSiShares MSCI China Small-Cap ETF0.04%28/02/2026
CXSEWisdomTree China ex-State-Owd Entpr ETF0.03%27/02/2026
XSOEWisdomTree EmMkts ex-Stt-Ownd EntrprsETF0.02%27/02/2026
EEMSiShares MSCI Emerging Markets Sm-Cp ETF0.02%28/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
GXCState Street® SPDR® S&P® China ETF0.01%27/02/2026
TLTEFlexShares Mstar EmgMkts FctTilt ETF0.001%27/02/2026
EWXState Street® SPDR® S&P® EM Sm Cp ETF<0.000001%22/09/2025
GINNGoldman Sachs Innovate Equity ETF<0.000001%24/11/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.